Hybio Pharmaceutical Co., Ltd.
300199
Rank in Stocks
#4739
Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical... Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical Co., Ltd. specializes in the global research, development, manufacturing, and commercialization of therapeutic peptide active pharmaceutical ingredients (APIs) and polypeptide medications. Its diverse product range addresses therapeutic needs such as diabetes (including liraglutide, semaglutide, and exenatide), gastrointestinal and metabolic disorders (with examples like terlipressin, desmopressin, and linaclotide), as well as applications in obstetrics and gynecology (featuring ganirelix, cetrorelix, and atosiban). Additionally, the company supplies custom peptides and provides essential working standards for peptide APIs and their impurities, offering comprehensive support for development initiatives. Beyond products, Hybio extends its expertise through Contract Research Organization (CRO) and an extensive Contract Development and Manufacturing Organization (CDMO) platform. This platform covers peptide API synthesis and purification process optimization, finished dosage form conceptualization, reference standard preparation and rigorous qualification, detailed impurity and product quality analysis, Good Manufacturing Practice (GMP) systems adhering to both EU and FDA benchmarks, and comprehensive regulatory and dossier support for both international and Chinese markets.
Share Price
$3.69
Market Cap
$3.11B
Change (1 day)
-7.75%
Change (1 year)
21.56%
Country
CN
Trade Hybio Pharmaceutical Co., Ltd. (300199)
Category
Healthcare
Dividend history for Hybio Pharmaceutical Co., Ltd. (300199)
Hybio Pharmaceutical Co., Ltd. (stock symbol: 300199) made a total of 6 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.49
Dividend yield (TTM) : 0
The sum of all dividends (adjusted for stock splits) is : $0.49
Dividend yield (TTM) : 0
Dividend payments for Hybio Pharmaceutical Co., Ltd. (300199) from 2012 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.2 | 0.00% |
| 2018 | $0.2 | 100.00% |
| 2017 | $0.1 | 300.00% |
| 2016 | $0.025 | -50.00% |
| 2015 | $0.05 | 0.00% |
| 2013 | $0.05 | -20.00% |
| 2012 | $0.0625 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.2 | 0.00% |
| 2018 | $0.2 | 100.00% |
| 2017 | $0.1 | 300.00% |
| 2016 | $0.025 | -75.00% |
| 2015 | $0.1 | -50.00% |
| 2013 | $0.2 | -60.00% |
| 2012 | $0.5 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 2.00% |
CH
|
|
| 39.00% |
IN
|
